New finasteride trial results aim to curb controversy.
Bankhead
Charles
C
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D018120:Finasteride; D017430:Prostate-Specific Antigen